You can turn it around as you want, but the BioNTech share may have had a disappointing development on the…
Read More »BNT162
Yesterday, some investors on NASDAQ took profits on BioNTech shares. The minus on the closing price basis of 6.6 percent…
Read More »BioNTech and Pfizer have already sold part of the planned production of a vaccine against SARS-CoV-2 that is currently under…
Read More »